← All trials
NCT06175273
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 31, 2024
- Primary completion
- Dec 31, 2024
- Completion date
- Jul 31, 2025
- First posted
- Dec 18, 2023
- Last posted
- Dec 18, 2023
- Enrollment
- 45
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of KentuckyLead sponsor
- National Center for Advancing Translational Science (NCATS)Collaborator
- University of KentuckySponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.